TGA Approval

CIPLA PACLITAXELPaclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial (328529)

ARTG ID

328529

ARTG Name

CIPLA PACLITAXELPaclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Sponsor

Cipla Australia Pty Ltd

ARTG Date

October 29, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

Ingredient Name

paclitaxel

Empowering clinical research with data-driven insights and AI-powered tools.